302 related articles for article (PubMed ID: 26198031)
1. TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-κB-induced increase in cFLIP.
Seol JY; Mihich E; Berleth ES
Cytokine; 2015 Oct; 75(2):321-9. PubMed ID: 26198031
[TBL] [Abstract][Full Text] [Related]
2. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
[TBL] [Abstract][Full Text] [Related]
3. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma.
Okano H; Shiraki K; Inoue H; Kawakita T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Fujikawa K; Murata K; Nakano T
Lab Invest; 2003 Jul; 83(7):1033-43. PubMed ID: 12861043
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.
Kreuz S; Siegmund D; Scheurich P; Wajant H
Mol Cell Biol; 2001 Jun; 21(12):3964-73. PubMed ID: 11359904
[TBL] [Abstract][Full Text] [Related]
5. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
[TBL] [Abstract][Full Text] [Related]
9. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
10. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
11. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H
Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820
[TBL] [Abstract][Full Text] [Related]
12. cFLIP regulates death receptor-mediated apoptosis in an ovarian granulosa cell line by inhibiting procaspase-8 cleavage.
Matsuda F; Inoue N; Goto Y; Maeda A; Cheng Y; Sakamaki K; Manabe N
J Reprod Dev; 2008 Oct; 54(5):314-20. PubMed ID: 18603835
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
15. Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-κB-dependent cFLIP expression in HeLa cells.
Seo OW; Kim JH; Lee KS; Lee KS; Kim JH; Won MH; Ha KS; Kwon YG; Kim YM
Exp Mol Med; 2012 Nov; 44(11):653-64. PubMed ID: 22932446
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
[TBL] [Abstract][Full Text] [Related]
17. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
18. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis.
García S; Mera A; Gómez-Reino JJ; Conde C
Rheumatology (Oxford); 2009 May; 48(5):483-9. PubMed ID: 19228791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]